VKTX Viking Pharma Kelajakdagi narxning foydaga nisbati

Viking Pharma (VKTX) tovar belgisi

Viking Therapeutics keyingi avlod molekulalarini yaratuvchi, semizlikka qarshi davolash vositalarini ishlab chiqish bo'yicha yetakchi kompaniyadir. Kompaniyaning GURU.Markets vaqt grafikidagi 12 oylik forward P/E ko'rsatkichi baholash dinamikasini aks ettiradi, bunda 0.00 indikatori metrikaning holatini ifodalaydi. Biznes samaradorligi AI algoritmlari va robotlashtirilgan dori vositalarini kashf etishga asoslangan, operatsion model esa ishlab chiqarish quvvatlarining uzoq muddatli autsorsingiga tayanadi.

VKTX - Viking Therapeutics, Inc. Kapitalizatsiyaning prognoz qilingan foydaga nisbati 04.07.2022 - 17.11.2026 oraligʻida

VKTX (Viking Therapeutics, Inc.): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- bozor kapitallashuvi bo'yicha ma'lumotlar:
Fundamental baholash:Viking Therapeutics, Inc. VKTX
vikingtherapeutics.com brendining mahsuloti

Investorlar aktivning operatsion barqarorligini bozor qiymatining kutilayotgan yillik daromadlarga nisbatiga qarab baholaydilar, bu esa GURU.Markets platformasiga kompaniyaning forward P/E koeffitsiyenti orqali kutishlar va real risklar o'rtasidagi muvozanatni vizuallashtirish imkonini beradi. Viking Therapeutics (VKTX) uchun ushbu ko'rsatkich metabolik buzilishlarga qarshi dori vositalarining diversifikatsiyalashgan portfeli qiymatini aks ettiradi, bunda bir nechta molekulalarning ishlab chiqilishi yagona patentga bog'liqlikni kamaytiradi va biznesning fundamental hayotiyligini tasdiqlaydi.

Muhim raqobatchilar

Forvard P/E multiplikatori BIIB|NBIX - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori RGC (Regencell Bioscience Ltd)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati axsome.com (AXSM)|ACADIA Pharmaceuticals Inc - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Xenon Pharmaceuticals Inc.|Supernus Pharma (SUPN) - Kelajakdagi narxning foydaga nisbati|CPRX (Catalyst Pharmaceuticals) - Kelajakdagi narxning foydaga nisbati|DNLI (denalitherapeutics.com) - Forvard P/E multiplikatori|Narxning kelajakdagi foydaga nisbati HRMY (Harmony Biosciences Holdings, Inc.)|Forvard P/E multiplikatori BHVN|AMLX (Amylyx Pharmaceuticals Inc) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori TRVI (Trevi Pharma)|PRAX (Praxis Corp) - Narxning kutilayotgan foydaga nisbati|anavex.com - Forvard P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori CBLL (CeriBell, Inc.)|PRTA: Forvard P/E multiplikatori|Narxning kelajakdagi foydaga nisbati ALEC|ANNX (Annexon Biosciences Inc.) - Forvard P/E multiplikatori|omeros.com - Narxning kutilayotgan foydaga nisbati|Kelajakdagi narxning foydaga nisbati Neurogene (NGNE)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati AC Immune SA|Forvard P/E multiplikatori VYGR (voyagertherapeutics.com)|Forvard P/E multiplikatori Neumora NMRA|Scilex Holding - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Tevogen Bio Inc.|Alpha Cognition (ACOG) - Kelajakdagi narxning foydaga nisbati|cogrx.com (CGTX) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati Inhibikase Therapeutics|Cassava (SAVA) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Kelajakdagi narxning foydaga nisbati Assertio Therapeutics (ASRT)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Coya|Vistagen - Prognoz qilingan narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori OVID|Acumen Pharmaceuticals Inc. - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati CervoMed Inc|ATHE: Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Clene Nanomedicine|Kelajakdagi narxning foydaga nisbati PepGen Corp|Jupiter Neurosciences (JUNS) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Kelajakdagi narxning foydaga nisbati Relmada Therapeutics, Inc. (RLMD)|ANVS - Prognoz qilingan narx-foyda nisbati|gracetx.com - Prognoz qilingan narxning foydaga nisbati|AIFF: Narxning kelajakdagi foydaga nisbati|Klotho Neurosciences - Forvard P/E multiplikatori|NRSN (NeuroSense Therapeutics Ltd.) - Narxning kelajakdagi foydaga nisbati|Reviva Pharmaceuticals (RVPH) - Kelajakdagi narxning foydaga nisbati|MTVA (MetaVia Inc.) - Kelajakdagi narxning foydaga nisbati|Kelajakdagi narxning foydaga nisbati NeurAxis, Inc|Kelajakdagi narxning foydaga nisbati HSDT|Forvard P/E multiplikatori PASG|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Neuphoria Therapeutics, Inc.|minervaneurosciences.com - Prognoz qilingan narxning foydaga nisbati|Forvard P/E multiplikatori Athira ATHA|Addex Therapeutics - Forvard P/E multiplikatori|ALZN - Forvard P/E multiplikatori|Cyclerion (CYCN) - Kelajakdagi narxning foydaga nisbati|Protagenic (PTIX) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati Pasithea|Narxning kelajakdagi foydaga nisbati CRGT (Cortigent)|Kelajakdagi narxning foydaga nisbati Avenue Therapeutics (ATXI)|BCLI - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori CARA (Cara Therapeutics Inc)|CHRO - Prognoz qilingan narxning foydaga nisbati|ELYM: Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Intra-Cellular Therapies, Inc. ITCI|Longboard Pharma (LBPH) - Kelajakdagi narxning foydaga nisbati|Marinus - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati NKGen Biotech Inc|NRBO: Kelajakdagi narx-foyda multiplikatori|Prognoz qilingan narxning foydaga nisbati SAGE (Sage Therapeutics, Inc.)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Neurotrope|Kelajakdagi narxning foydaga nisbati Trevena, Inc. TRVN|Vigil Neuroscience (VIGL) - Prognoz qilingan narx-foyda nisbati|WENA: Prognoz qilingan narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori CERE (Cerevel Therapeutics)